The effect of administration of blood thinners through a naso-gastrc tube.

• Conditions: Patients surviving cardiac arrest and undergoing percutaneous coronary intervention; MedDRA version: 16.1Level: LLTClassification code 10067273Term: Acute transmural myocardial infarctionSystem Organ Class: 100000004849; Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]; MedDRA version: 16.1Level: LLTClassification code 10064347Term: Non ST segment elevation myocardial infarctionSystem Organ Class: 100000004849

• Registration Number: EUCTR2013-005529-22-DK
• Lead Sponsor: Rigshospitalet

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-02-12
• Last Update Posted: 18 January 2016

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Cardiac arrest, recent PCI and need for oral antithrombotic treatment through a nasogastric tube.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 20

Exclusion Criteria

Ongoing bleeding.
Pregnancy
No need (byclinical indication) for oral antithrombotic treatment

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified